Echocardiography and Peak Endocardial Acceleration (PEA) Measurements in Cardiac Resynchronization Therapy (CRT)

Echocardiography and PEA Measurements in CRT Therapy

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01066078

Enrollment

216

Registered

2010-02-10

Start date

2007-10-31

Completion date

2009-10-31

Last updated

2010-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congestive Heart Failure

Keywords

heart failure - congestive, Cardiovascular imaging agents/Techniques], Echocardiography, Other diagnostic testing, Other Treatment, Recipients of cardiac resynchronization therapy systems

Brief summary

This study used an external endocardial acceleration sensor (sonR sensor), placed on the patient's chest, to time the closure of aortic and mitral valves, and compared its performance with echocardiography.

Interventions

OTHEREchocardiography and SonR recording

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Every patient coming in the participating centers for an echocardiographic exam and implanted with a pacemaker or an implantable cardioverter defibrillator (ICD) can be included in the study.

Exclusion criteria

* Inability to understand the patient information sheet. * Minor patient or pregnant woman.

Design outcomes

Primary

Measure	Time frame
The timings of mitral (tMC) and aortic (tAC) valves closure by echocardiography and sonR	12 months

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026